Clinical Trial: Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional



Official Title: Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali

Brief Summary:

The purpose of this study is to determine the highest tolerable dose of primaquine within 0.75 mg/kg. A tolerable dose is defined as one in which:

  • Two or fewer participants (< 30%) experience hemolysis;
  • No participant experiences a drug-related serious adverse event; and
  • No participant requires a blood transfusion.